Clinical Trial

CBCT Guided Markerless SBRT for Renal Cell Cancer

Name: CBCT Guided Markerless SBRT for Renal Cell Cancer — clinical trial record (NCT07402109)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CT-STARRS

Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-09

Trial Details

NCT Number	NCT07402109
Lead Sponsor	Erasmus Medical Center
Conditions	Renal Cell Carcinoma (RCC)
Enrollment	40 participants
Start Date	2026-04-01
Primary Completion	2030-01-01 (estimated)
Study Completion	2030-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-08